Our analysis revealed that mutations in OSRE such as MGST3, GSTP1, NDUFS2, NDUFS8 and PRDX6 were particularly prevalent in breast cancer, and for the five genes the most prevalent genetic alteration was amplification. Here, PRDX6 is linked to breast carcinoma.